GALNT9 and BNC1 promoter methylation and associated silencing is common in BBM but does not occur frequently in the originating breast tumours suggesting that their dysregulation may not necessarily benefit the primary tumour but are required for successful colonization of the brain. The gene discussed is GALNT9; the disease is breast neoplasm.